1. Home
  2. MASS vs PFX Comparison

MASS vs PFX Comparison

Compare MASS & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASS
  • PFX
  • Stock Information
  • Founded
  • MASS 2012
  • PFX 2010
  • Country
  • MASS United States
  • PFX United States
  • Employees
  • MASS N/A
  • PFX N/A
  • Industry
  • MASS Medical/Dental Instruments
  • PFX Finance: Consumer Services
  • Sector
  • MASS Health Care
  • PFX Finance
  • Exchange
  • MASS Nasdaq
  • PFX Nasdaq
  • Market Cap
  • MASS 117.5M
  • PFX 99.3M
  • IPO Year
  • MASS 2020
  • PFX N/A
  • Fundamental
  • Price
  • MASS $2.74
  • PFX $46.86
  • Analyst Decision
  • MASS Buy
  • PFX
  • Analyst Count
  • MASS 3
  • PFX 0
  • Target Price
  • MASS $8.00
  • PFX N/A
  • AVG Volume (30 Days)
  • MASS 346.0K
  • PFX 1.1K
  • Earning Date
  • MASS 11-12-2024
  • PFX 12-20-2024
  • Dividend Yield
  • MASS N/A
  • PFX N/A
  • EPS Growth
  • MASS N/A
  • PFX 36.92
  • EPS
  • MASS N/A
  • PFX 9.66
  • Revenue
  • MASS $55,162,000.00
  • PFX $22,293,269.00
  • Revenue This Year
  • MASS $29.30
  • PFX $19.50
  • Revenue Next Year
  • MASS $26.50
  • PFX $9.74
  • P/E Ratio
  • MASS N/A
  • PFX $4.85
  • Revenue Growth
  • MASS 16.08
  • PFX 14.03
  • 52 Week Low
  • MASS $2.19
  • PFX $37.00
  • 52 Week High
  • MASS $12.51
  • PFX $50.00
  • Technical
  • Relative Strength Index (RSI)
  • MASS 35.98
  • PFX 46.37
  • Support Level
  • MASS $2.32
  • PFX $44.56
  • Resistance Level
  • MASS $2.61
  • PFX $47.11
  • Average True Range (ATR)
  • MASS 0.25
  • PFX 0.92
  • MACD
  • MASS -0.08
  • PFX -0.03
  • Stochastic Oscillator
  • MASS 18.28
  • PFX 42.37

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About PFX PhenixFIN Corporation

PhenixFIN Corp formerly Medley Capital Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: